Iambic Therapeutics, Inc.

Biotechnology company · San Diego, California, United States

Iambic Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $28 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Iambic Therapeutics at a glance

Typebiotechnology company

HeadquartersSan Diego, California, United States

Earliest incorporation on record2019

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1997038

What does Iambic Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $27.8 million sold (2026).

Frequently asked questions about Iambic Therapeutics

Where is Iambic Therapeutics headquartered?

Iambic Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Iambic Therapeutics do?

Iambic Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Iambic Therapeutics founded?

The earliest incorporation on record for Iambic Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

BioAtla, Inc.San Diego, California, United States
Neurocrine Biosciences IncSan Diego, California, United States
ImmunityBio, Inc.San Diego, California, United States
Sorrento Therapeutics, Inc.San Diego, California, United States
Protego Biopharma, Inc.San Diego, California, United States
Tempo Therapeutics, Inc.San Diego, California, United States
Fate Therapeutics IncSan Diego, California, United States
ImageneBio, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences